Acelrx Pharmaceutica (ACRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ACRX | CANF | XTLB | ||
| Company | Acelrx Pharmaceutica | Can-Fite Biopharma Ltd ADR | Xtl Biopharma ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE Arca | NASDAQ | ||
| Open | 0.7811 | 4.55 | 2.49 | ||
| High | 0.8775 | 4.69 | 2.75 | ||
| Low | 0.7784 | 3.75 | 2.48 | ||
| Last | 0.8600 | 3.81 | 2.74 | ||
| Change | +0.0600 | -0.69 | +0.17 | ||
| % Change | +7.50% | -15.33% | +6.62% | ||
| Volume | 243,500 | 321,462 | 40,300 | ||
| 20-Day Average Volume | 154,540 | 113,460 | 11,835 | ||
| Previous Close | 0.8000 | 4.50 | 2.57 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.7658 | 3.08 | 2.40 | ||
| 20-Day Raw Stochastic | 91.56% | 63.18% | 94.29% | ||
| 20-Day Relative Strength | 61.32% | 61.56% | 57.84% | ||
| Weighted Alpha | -53.04 | -5.32 | +25.36 | ||
| Today's Opinion | 24% Buy | 100% Buy | 88% Buy | ||
| Previous Opinion | 8% Sell | 100% Buy | 88% Buy | ||
| Last Month's Opinion | 24% Sell | 100% Buy | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +16.15% since 01/02/24 | +13.06% since 07/15/24 | +10.04% since 07/15/24 | ||
| Low | 0.7300 on 01/03/24 | 3.38 on 07/16/24 | 2.43 on 07/19/24 | ||
| High | 0.8775 on 01/09/24 | 4.69 on 07/22/24 | 2.75 on 07/22/24 | ||
| 1-Month | |||||
| %Chg | +18.03% since 12/08/23 | +39.82% since 06/21/24 | +22.60% since 06/21/24 | ||
| Low | 0.6701 on 12/12/23 | 2.30 on 07/05/24 | 2.08 on 06/27/24 | ||
| High | 0.8775 on 01/09/24 | 4.69 on 07/22/24 | 2.78 on 07/11/24 | ||
| 3-Month | |||||
| %Chg | +28.45% since 10/09/23 | +92.42% since 04/22/24 | +3.40% since 04/22/24 | ||
| Low | 0.4250 on 11/14/23 | 1.91 on 04/26/24 | 1.85 on 06/11/24 | ||
| High | 0.8775 on 01/09/24 | 4.69 on 07/22/24 | 3.15 on 05/21/24 | ||
| 6-Month | |||||
| %Chg | -33.85% since 07/07/23 | +94.39% since 01/22/24 | +223.80% since 01/22/24 | ||
| Low | 0.4250 on 11/14/23 | 1.91 on 04/26/24 | 0.77 on 02/26/24 | ||
| High | 1.4200 on 07/10/23 | 4.69 on 07/22/24 | 4.99 on 03/25/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 14,579 | 15,931 | 14,003 | ||
| Shares Outstanding, K | 16,952 | 3,540 | 5,449 | ||
| Annual Sales | 1,770,000 | 740,000 | 0 | ||
| Annual Net Income | 47,760,000 | -7,630,000 | -1,780,000 | ||
| Last Quarter Sales | 120,000 | 160,000 | 0 | ||
| Last Quarter Net Income | -1,360,000 | -1,650,000 | 490,000 | ||
| 60-Month Beta | 0.52 | 1.45 | 1.21 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.08 on 11/08/23 | -0.31 on 03/28/24 | 0.10 on 05/13/24 | ||
| Latest Earnings Date | 11/08/23 | 08/29/24 | 08/08/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||